AGP Executive Report
Last update: 3 hours agoPsychedelic Policy Shock (US): The Trump administration is pushing to legalize ibogaine, a Schedule I psychedelic, fast-tracking FDA review after veterans’ groups argued it could help with PTSD and traumatic brain injuries—while researchers report brain-scan-linked improvements after a single dose in Special Operations veterans. Neuroscience Update: A new study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging links ibogaine to lasting changes in cerebral blood flow and neural network reorganization. Ebola Emergency (Central Africa): WHO declared the Bundibugyo Ebola outbreak a Public Health Emergency of International Concern as cases rise across the DRC and Uganda, with health systems strained and no targeted vaccine or treatment for this strain. Gabon Context: Gabon’s traditional iboga use is again in the spotlight as global regulators weigh medical claims. Regional Health Watch: Nigeria also reported a major human-trafficking crackdown—an indirect reminder that health risks spread fast when people are exploited and moved across borders.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
